ArticleScientific reports2025

LEM4 interacts with β-catenin and promotes β-catenin-dependent transcription activity to confers ribociclib resistance in breast cancer cells.

Qi Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.